Effect of extending the duration of carboplatin infusion in decreasing of hypersensitivity reaction in retreatment gynecologic cancer pateints

Not Applicable

Active, not recruiting

• Conditions: Retreatment gynecological cancerOvarian cancerPeritoneal cancerHypersensitivity reaction; Carboplatin; Retreatment; Gynecological cancer; Ovarian cancer; Peritoneal cancer; Hypersensitivity reaction; Anaphylaxis; Adverse drug reactions

• Registration Number: TCTR20151123001
• Lead Sponsor: none

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-11-23
• Study Completion: 2016-06-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: Female
• Target Recruitment: 126

Inclusion Criteria

1. Gynecological cancer patients age between 25-80 years old
2. Historically treated by carboplatin-included regimen at least 6 cycles
3. Need for retreatment by carboplatin-included regimen again

Exclusion Criteria

1. Historically occured of hypersensitivity reaction to carboplatin
2. No history of treatment by carboplatin

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hypersensitivity occuring rate At the day of chemotherapy was administered The data about hypersensitivity at the day of chemotherapy was administered will be recorded by the

Secondary Outcome Measures

Name	Time	Method
none none none